tirzepatide cardiovascular outcomes trial results august 2025 60-Second Journal Club: The SUMMIT examined of treatment with in patients with heart failure with preserved ejection fraction and obesity. Read the full trial SURPASS-CVOT Published: Large Trial Confirms

Semaglutide treatment at a dose of 1 mg weekly resulted in an 11 kg weight reduction over nine months, followed by an additional 7 kg weight loss over the next eleven months, once the dosage was elevated to 2 mg weekly

Most active players and API purchasers alike continue to source from China, making Chinese API supply a central variable in Indias GLP-1 economics regardless of how many domestic brands ultimately reach the market

Individuals taking L-carnitine as a sports supplement to improve fat metabolism and muscular performance should stop using it at least for one week each month

Nausea Nausea is the most commonly reported tirzepatide side effect

Nutricia (Danone) is embedding GLP-1 formulations in EU medical food programs

Studies have shown that about 25% of the weight loss that occurs from dieting is lean body mass [4] and that rapid weight loss, like what occurs with GLP1s, is associated with more loss of lean body mass than those who achieve a slower weight loss